Total Payments
$4,903
2024 Payments
$185.52
Companies
33
Transactions
343
Medicare Patients
1,494
Medicare Billing
$93,754
Payment Breakdown by Category
Food & Beverage$4,903 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,903 | 343 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,012 | 83 | $0 (2023) |
| GlaxoSmithKline, LLC. | $561.41 | 71 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $511.94 | 22 | $0 (2022) |
| Amgen Inc. | $319.91 | 22 | $0 (2023) |
| Lilly USA, LLC | $277.56 | 27 | $0 (2023) |
| Biosense Webster, Inc. | $262.56 | 8 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $243.56 | 14 | $0 (2023) |
| Astellas Pharma US Inc | $241.87 | 11 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $172.66 | 12 | $0 (2022) |
| Amarin Pharma Inc. | $170.99 | 14 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $185.52 | 4 | AIMMUNE THERAPEUTICS, INC. ($124.03) |
| 2023 | $658.22 | 28 | Biosense Webster, Inc. ($247.04) |
| 2022 | $2,225 | 182 | ABBVIE INC. ($447.45) |
| 2021 | $1,834 | 129 | AbbVie Inc. ($413.46) |
All Payment Transactions
343 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/25/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $124.03 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Oncology | ||||||
| 02/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Biological | ||||||
| 01/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/16/2023 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: Cardiology | ||||||
| 11/08/2023 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $37.06 | General |
| Category: Cardiology | ||||||
| 10/04/2023 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: Cardiology | ||||||
| 08/31/2023 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $91.50 | General |
| Category: Cardiology | ||||||
| 08/17/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: NEUROLOGY | ||||||
| 07/27/2023 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $38.10 | General |
| Category: Cardiology | ||||||
| 07/13/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Diabetes Care | ||||||
| 06/30/2023 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $38.84 | General |
| Category: Cardiology | ||||||
| 06/27/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Biological | ||||||
| 06/21/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Biological | ||||||
| 06/09/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: Biological | ||||||
| 05/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: NEUROLOGY | ||||||
| 04/13/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: INSOMNIA | ||||||
| 03/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: RESPIRATORY | ||||||
| 02/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2023 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $3.91 | General |
| Category: Cardiology | ||||||
| 02/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: RESPIRATORY | ||||||
| 01/24/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 68 | 69 | $21,421 | $3,637 |
| 2022 | 16 | 563 | 999 | $165,720 | $37,046 |
| 2021 | 11 | 437 | 746 | $136,878 | $31,360 |
| 2020 | 11 | 426 | 660 | $93,834 | $21,711 |
Total Patients
1,494
Total Services
2,474
Medicare Billing
$93,754
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 50 | $16,911 | $2,753 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 19 | $4,510 | $883.07 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 196 | 369 | $116,235 | $24,574 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 103 | 135 | $29,700 | $7,029 | 23.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 42 | 53 | $7,640 | $2,288 | 30.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 29 | 71 | $2,840 | $1,169 | 41.2% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 26 | 31 | $2,320 | $533.17 | 23.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 31 | 62 | $3,100 | $444.60 | 14.3% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 12 | 15 | $1,300 | $271.78 | 20.9% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 14 | 21 | $525.00 | $261.08 | 49.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 11 | 11 | $440.00 | $180.17 | 40.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 14 | $490.00 | $109.95 | 22.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 21 | 25 | $375.00 | $55.53 | 14.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 15 | 60 | $240.00 | $46.89 | 19.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 11 | 12 | $156.00 | $37.94 | 24.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 12 | 12 | $192.00 | $27.36 | 14.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 12 | 52 | $156.00 | $12.67 | 8.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 14 | 56 | $11.20 | $4.65 | 41.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 172 | 338 | $102,339 | $22,928 | 22.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 106 | $22,720 | $5,446 | 24.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 17 | 19 | $2,660 | $859.37 | 32.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 31 | 74 | $3,700 | $644.73 | 17.4% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 26 | 34 | $2,378 | $554.43 | 23.3% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 15 | 29 | $1,160 | $479.95 | 41.4% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2021 | 26 | 28 | $364.00 | $145.10 | 39.9% |
About Sandra Flores, NP
Sandra Flores, NP is a Family healthcare provider based in Abilene, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/17/2009. The National Provider Identifier (NPI) number assigned to this provider is 1043549249.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sandra Flores, NP has received a total of $4,903 in payments from pharmaceutical and medical device companies, with $185.52 received in 2024. These payments were reported across 343 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,903).
As a Medicare-enrolled provider, Flores has provided services to 1,494 Medicare beneficiaries, totaling 2,474 services with total Medicare billing of $93,754. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Abilene, TX
- Active Since 12/17/2009
- Last Updated 03/30/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1043549249
Products in Payments
- TRELEGY ELLIPTA (Drug) $459.60
- VRAYLAR (Drug) $371.81
- FARXIGA (Drug) $310.71
- JARDIANCE (Drug) $299.30
- QULIPTA (Drug) $287.57
- CARTO 3 (Device) $262.56
- UBRELVY (Drug) $234.47
- TRULICITY (Drug) $211.81
- BREZTRI (Drug) $201.23
- REXULTI (Drug) $172.66
- ZENPEP (Drug) $171.90
- Vascepa (Drug) $170.99
- Otezla (Drug) $167.05
- Aimovig (Biological) $152.86
- NURTEC ODT (Drug) $105.05
- Veozah (Drug) $97.14
- WATCHMAN Access System (Device) $83.98
- SHINGRIX (Biological) $79.78
- MYRBETRIQ (Drug) $79.43
- ENTRESTO (Drug) $73.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Abilene
Teresa Sowa, Np-C, NP-C
Family — Payments: $4,749
Family $4,749
Mrs. Kathryn Barton, Rn, Fnp-C, RN, FNP-C
Family — Payments: $4,681
Family $4,681
Linda Larsen, Rn Np-C, RN NP-C
Family — Payments: $4,675
Family $4,675
Holly Mansur, Fnp-C, FNP-C
Family — Payments: $4,086
Family $4,086
Rachel Brown, Aprn Fnp-C, APRN FNP-C
Family — Payments: $3,511
Family $3,511
Zarina Calingo, Np-C, NP-C
Family — Payments: $3,323
Family $3,323